Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




WHO Adopts New Safety Needle Policy

By HospiMedica International staff writers
Posted on 11 May 2015
The World Health Organization (WHO; Geneva, Switzerland) has launched a new policy to make unsafe injections less prevalent by promoting the use of safety-engineered syringes for intramuscular, intradermal, and subcutaneous injections.

WHO is urging countries to transition by 2020 to the exclusive use of the smart syringes, except in select circumstances, such as syringe programs for people who inject themselves with drugs and medication. More...
As part of that initiative, manufacturers are urged as soon as possible to begin or expand their production of smart syringes. Other key strategies recommended are continued training of health workers on injection safety, and the implementation of policies and standards for the procurement, safe use, and safe disposal of syringes that have the potential for reuse.

Several smart syringe design options exist, including a syringe with a plunger that breaks if the user attempts to pull it back a second time, others that have a clip to block the same movement; some syringes utilize retracting needles that prevent a second use. Syringes are also being designed with features that protect health workers from needle stick injuries, such as a sheath or hood that slides over the needle after the injection is completed, which protect the user from being accidental needle-stick injury, and potentially exposed to an infection.

According to WHO, 16 billion injections are administered annually, with 5% of these injections used for immunization, and another 5% used for procedures such as blood transfusions and injectable contraceptives. The remaining 90% of injections are given in an intramuscular, subcutaneous, or intradermal route for administration of medication. WHO therefore stressed the need to reduce the number of unnecessary injections as a way of reducing risk, since in many cases these injections are unnecessary or could be replaced by oral delivery.

“We know the reasons why this is happening. One reason is that people in many countries expect to receive injections, believing they represent the most effective treatment,” said Edward Kelley, MD, director of the WHO service delivery and safety department. “Another is that for many health workers in developing countries, giving injections in private practice supplements salaries that may be inadequate to support their families.”

A 2014 study sponsored by WHO estimated that in 2010 unsafe injections resulted in up to 1.7 million people infected with Hepatitis B virus, up to 315,000 with Hepatitis C virus, and as many as 33,800 with HIV. WHO also cited several cases in which an unsafe injection protocol has led to the unnecessary outbreak of infectious disease. In 2007, a doctor in Nevada (USA) reused hepatitis C-contaminated syringes. In Cambodia, more than 200 children and adults tested positive for HIV, in an outbreak that is thought to have occurred due to unsafe injections.

Related Links:

World Health Organization



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.